Indiana 2025 Regular Session

Indiana Senate Bill SB0386 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11
22 Introduced Version
33 SENATE BILL No. 386
44 _____
55 DIGEST OF INTRODUCED BILL
66 Citations Affected: IC 11-12-12; IC 25-26-24-19; IC 36-8-10-21.
77 Synopsis: Community corrections programs. Establishes a community
88 corrections commissary fund (fund). Provides that the director of the
99 community corrections program, or the director's designee, shall
1010 deposit all money from a commissary that sells merchandise to
1111 participants in the particular community corrections program into the
1212 fund. Provides that a community corrections officer may sell
1313 merchandise from a commissary to a participant of the community
1414 corrections program. Provides that the director of a residential
1515 community corrections program, or the director's designee, may receive
1616 confidential information from the Indiana scheduled prescription
1717 electronic collection and tracking (INSPECT) program.
1818 Effective: July 1, 2025.
1919 Goode
2020 January 13, 2025, read first time and referred to Committee on Corrections and Criminal
2121 Law.
2222 2025 IN 386—LS 6178/DI 116 Introduced
2323 First Regular Session of the 124th General Assembly (2025)
2424 PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
2525 Constitution) is being amended, the text of the existing provision will appear in this style type,
2626 additions will appear in this style type, and deletions will appear in this style type.
2727 Additions: Whenever a new statutory provision is being enacted (or a new constitutional
2828 provision adopted), the text of the new provision will appear in this style type. Also, the
2929 word NEW will appear in that style type in the introductory clause of each SECTION that adds
3030 a new provision to the Indiana Code or the Indiana Constitution.
3131 Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
3232 between statutes enacted by the 2024 Regular Session of the General Assembly.
3333 SENATE BILL No. 386
3434 A BILL FOR AN ACT to amend the Indiana Code concerning
3535 corrections.
3636 Be it enacted by the General Assembly of the State of Indiana:
3737 1 SECTION 1. IC 11-12-12 IS ADDED TO THE INDIANA CODE
3838 2 AS A NEW CHAPTER TO READ AS FOLLOWS [EFFECTIVE
3939 3 JULY 1, 2025]:
4040 4 Chapter 12. Community Corrections Program Commissary
4141 5 Sec. 1. This chapter applies to a community corrections
4242 6 program that consists of a residential facility and work release
4343 7 program.
4444 8 Sec. 2. This chapter does not apply to a jail commissary
4545 9 described in IC 36-8-10-21.
4646 10 Sec. 3. As used in this chapter, "fund" refers to a community
4747 11 corrections commissary fund established by section 4 of this
4848 12 chapter.
4949 13 Sec. 4. (a) The community corrections commissary fund is
5050 14 established. The fund is separate from any other fund, and money
5151 15 in the fund does not revert to any other fund.
5252 16 (b) The director of the community corrections program, or the
5353 17 director's designee, shall deposit all money from a commissary that
5454 2025 IN 386—LS 6178/DI 116 2
5555 1 sells merchandise to participants in the particular community
5656 2 corrections program into the fund. The director of the community
5757 3 corrections program, or the director's designee, shall keep the fund
5858 4 in a depository designated under IC 5-13-8.
5959 5 (c) The director of the community corrections program, or the
6060 6 director's designee, at the program director's or the director's
6161 7 designee's discretion and without appropriation by the county
6262 8 fiscal body, may disburse money from the fund for:
6363 9 (1) merchandise for resale to participants in the community
6464 10 corrections program through the commissary;
6565 11 (2) expenses of operating the commissary, including facilities
6666 12 and personnel;
6767 13 (3) training for employees of the community corrections
6868 14 program;
6969 15 (4) equipment installed in the residential facility;
7070 16 (5) equipment, including vehicles and computers, computer
7171 17 software, communication devices, office machinery and
7272 18 furnishings, cameras and photographic equipment, or attire
7373 19 used by an employee of the community corrections program
7474 20 in the course of the employee's official duties;
7575 21 (6) an activity provided to maintain order and discipline
7676 22 among the participants of the community corrections
7777 23 program;
7878 24 (7) an activity or program of the community corrections
7979 25 program intended to reduce or prevent occurrences of
8080 26 criminal activity; or
8181 27 (8) any other purpose that benefits the community corrections
8282 28 program that is mutually agreed upon by the community
8383 29 corrections advisory board and the director of the community
8484 30 corrections program.
8585 31 Money disbursed from the fund under this subsection must be
8686 32 supplemental or in addition to, rather than a replacement for,
8787 33 regular appropriations made to carry out the purposes listed in
8888 34 subdivisions (1) through (8).
8989 35 Sec. 5. A community corrections officer may sell merchandise
9090 36 from a commissary to a participant of the community corrections
9191 37 program.
9292 38 SECTION 2. IC 25-26-24-19, AS AMENDED BY P.L.233-2023,
9393 39 SECTION 5, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
9494 40 JULY 1, 2025]: Sec. 19. (a) Information received by the INSPECT
9595 41 program under section 17 of this chapter is confidential.
9696 42 (b) The board shall carry out a program to protect the confidentiality
9797 2025 IN 386—LS 6178/DI 116 3
9898 1 of the information described in subsection (a). The board may disclose
9999 2 the information to another person only under subsection (c), (d), or (g).
100100 3 (c) The board may disclose confidential information described in
101101 4 subsection (a) to any person who is authorized to engage in receiving,
102102 5 processing, or storing the information.
103103 6 (d) Except as provided in subsections (e) and (f), the board may
104104 7 release confidential information described in subsection (a) to the
105105 8 following persons:
106106 9 (1) A member of the board or another governing body that
107107 10 licenses practitioners and is engaged in an investigation, an
108108 11 adjudication, or a prosecution of a violation under any state or
109109 12 federal law that involves ephedrine, pseudoephedrine, or a
110110 13 controlled substance.
111111 14 (2) An investigator for the consumer protection division of the
112112 15 office of the attorney general, a prosecuting attorney, the attorney
113113 16 general, a deputy attorney general, or an investigator from the
114114 17 office of the attorney general, who is engaged in:
115115 18 (A) an investigation;
116116 19 (B) an adjudication; or
117117 20 (C) a prosecution;
118118 21 of a violation under any state or federal law that involves
119119 22 ephedrine, pseudoephedrine, or a controlled substance.
120120 23 (3) A law enforcement officer, including a director of a
121121 24 residential community corrections program, or the director's
122122 25 designee, who is an employee of:
123123 26 (A) a local, state, or federal law enforcement agency; or
124124 27 (B) an entity that regulates ephedrine, pseudoephedrine, or
125125 28 controlled substances or enforces ephedrine, pseudoephedrine,
126126 29 or controlled substances rules or laws in another state;
127127 30 that is certified to receive ephedrine, pseudoephedrine, or
128128 31 controlled substance prescription drug information from the
129129 32 INSPECT program.
130130 33 (4) A practitioner or practitioner's agent certified to receive
131131 34 information from the INSPECT program.
132132 35 (5) An ephedrine, pseudoephedrine, or controlled substance
133133 36 monitoring program in another state with which Indiana has
134134 37 established an interoperability agreement.
135135 38 (6) The state toxicologist.
136136 39 (7) A certified representative of the Medicaid retrospective and
137137 40 prospective drug utilization review program.
138138 41 (8) A substance abuse assistance program for a licensed health
139139 42 care provider who:
140140 2025 IN 386—LS 6178/DI 116 4
141141 1 (A) has prescriptive authority under this title; and
142142 2 (B) is participating in the assistance program.
143143 3 (9) An individual who holds a valid temporary medical permit
144144 4 issued under IC 25-22.5-5-4 or a noneducational commission for
145145 5 foreign medical graduates certified graduate permit issued under
146146 6 IC 25-22.5-5-4.6.
147147 7 (10) A county coroner conducting a medical investigation of the
148148 8 cause of death.
149149 9 (11) The management performance hub established by
150150 10 IC 4-3-26-8.
151151 11 (12) The state epidemiologist under the Indiana department of
152152 12 health.
153153 13 (e) Information provided to a person under:
154154 14 (1) subsection (d)(3) is limited to information:
155155 15 (A) concerning an individual or proceeding involving the
156156 16 unlawful diversion or misuse of a schedule II, III, IV, or V
157157 17 controlled substance; and
158158 18 (B) that will assist in an investigation or proceeding;
159159 19 (2) subsection (d)(4) may be released only for the purpose of:
160160 20 (A) providing medical or pharmaceutical treatment; or
161161 21 (B) evaluating the need for providing medical or
162162 22 pharmaceutical treatment to a patient; and
163163 23 (3) subsection (d)(11) must be released to the extent disclosure of
164164 24 the information is not prohibited by applicable federal law.
165165 25 (f) Before the board releases confidential information under
166166 26 subsection (d), the applicant must be approved by the INSPECT
167167 27 program in a manner prescribed by the board.
168168 28 (g) The board may release to:
169169 29 (1) a member of the board or another governing body that licenses
170170 30 practitioners;
171171 31 (2) an investigator for the consumer protection division of the
172172 32 office of the attorney general, a prosecuting attorney, the attorney
173173 33 general, a deputy attorney general, or an investigator from the
174174 34 office of the attorney general; or
175175 35 (3) a law enforcement officer, including a director of a
176176 36 residential community corrections program, or the director's
177177 37 designee, who is:
178178 38 (A) authorized by the state police department to receive
179179 39 ephedrine, pseudoephedrine, or controlled substance
180180 40 prescription drug information; and
181181 41 (B) approved by the board to receive the type of information
182182 42 released;
183183 2025 IN 386—LS 6178/DI 116 5
184184 1 confidential information generated from computer records that
185185 2 identifies practitioners who are prescribing or dispensing large
186186 3 quantities of a controlled substance.
187187 4 (h) The information described in subsection (g) may not be released
188188 5 until it has been reviewed by:
189189 6 (1) a member of the board who is licensed in the same profession
190190 7 as the prescribing or dispensing practitioner identified by the data;
191191 8 or
192192 9 (2) the board's designee;
193193 10 and until that member or the designee has certified that further
194194 11 investigation is warranted. However, failure to comply with this
195195 12 subsection does not invalidate the use of any evidence that is otherwise
196196 13 admissible in a proceeding described in subsection (i).
197197 14 (i) An investigator or a law enforcement officer, including a
198198 15 director of a residential community corrections program, or the
199199 16 director's designee, receiving confidential information under
200200 17 subsection (c), (d), or (g) may disclose the information to a law
201201 18 enforcement officer or an attorney for the office of the attorney general
202202 19 for use as evidence in the following:
203203 20 (1) A proceeding under IC 16-42-20.
204204 21 (2) A proceeding under any state or federal law.
205205 22 (3) A criminal proceeding or a proceeding in juvenile court.
206206 23 (j) The board may compile statistical reports from the information
207207 24 described in subsection (a). The reports must not include information
208208 25 that identifies any practitioner, ultimate user, or other person
209209 26 administering ephedrine, pseudoephedrine, or a controlled substance.
210210 27 Statistical reports compiled under this subsection are public records.
211211 28 (k) Except as provided in subsections (q) and (r), and in addition to
212212 29 any requirements provided in IC 25-22.5-13, the following practitioners
213213 30 shall obtain information about a patient from the data base either
214214 31 directly or through the patient's integrated health record before
215215 32 prescribing an opioid or benzodiazepine to the patient:
216216 33 (1) A practitioner who has had the information from the data base
217217 34 integrated into the patient's electronic health records.
218218 35 (2) A practitioner who provides services to the patient in:
219219 36 (A) the emergency department of a hospital licensed under
220220 37 IC 16-21; or
221221 38 (B) a pain management clinic.
222222 39 (3) Beginning January 1, 2020, a practitioner who provides
223223 40 services to the patient in a hospital licensed under IC 16-21.
224224 41 (4) Beginning January 1, 2021, all practitioners.
225225 42 However, a practitioner is not required to obtain information about a
226226 2025 IN 386—LS 6178/DI 116 6
227227 1 patient who is subject to a pain management contract from the data
228228 2 base more than once every ninety (90) days.
229229 3 (l) A practitioner who checks the INSPECT program either directly
230230 4 through the data base or through the patient's integrated health record
231231 5 for the available data on a patient is immune from civil liability for an
232232 6 injury, death, or loss to a person solely due to a practitioner:
233233 7 (1) seeking information from the INSPECT program; and
234234 8 (2) in good faith using the information for the treatment of the
235235 9 patient.
236236 10 The civil immunity described in this subsection does not extend to a
237237 11 practitioner if the practitioner receives information directly from the
238238 12 INSPECT program or through the patient's integrated health record and
239239 13 then negligently misuses this information. This subsection does not
240240 14 apply to an act or omission that is a result of gross negligence or
241241 15 intentional misconduct.
242242 16 (m) The board may review the records of the INSPECT program. If
243243 17 the board determines that a violation of the law may have occurred, the
244244 18 board shall notify the appropriate law enforcement agency or the
245245 19 relevant government body responsible for the licensure, regulation, or
246246 20 discipline of practitioners authorized by law to prescribe controlled
247247 21 substances.
248248 22 (n) A practitioner who in good faith discloses information based on
249249 23 a report from the INSPECT program either directly through the data
250250 24 base or through the patient's integrated health record to a law
251251 25 enforcement agency is immune from criminal or civil liability. A
252252 26 practitioner that discloses information to a law enforcement agency
253253 27 under this subsection is presumed to have acted in good faith.
254254 28 (o) A practitioner's agent may act as a delegate and check INSPECT
255255 29 program reports on behalf of the practitioner.
256256 30 (p) A patient may access a report from the INSPECT program that
257257 31 has been included in the patient's medical file by a practitioner.
258258 32 (q) A practitioner is not required under subsection (k) to obtain
259259 33 information about a patient from the data base or through the patient's
260260 34 integrated health record before prescribing an opioid or benzodiazepine
261261 35 if any of the following apply:
262262 36 (1) The practitioner has obtained a waiver from the board because
263263 37 the practitioner does not have access to the Internet at the
264264 38 practitioner's place of business.
265265 39 (2) The patient is:
266266 40 (A) recovering; or
267267 41 (B) in the process of completing a prescription that was
268268 42 prescribed by another practitioner;
269269 2025 IN 386—LS 6178/DI 116 7
270270 1 while still being treated as an inpatient or in observation status.
271271 2 (3) The data base described in section 18 of this chapter is
272272 3 suspended or is not operational if the practitioner documents in
273273 4 writing or electronically the date and time in the patient's medical
274274 5 record that the practitioner, dispenser, or delegate attempted to
275275 6 use the data base.
276276 7 (r) A practitioner is not required under subsection (k) to obtain
277277 8 information about a patient from the data base or through the patient's
278278 9 integrated health record before prescribing an opioid or benzodiazepine
279279 10 if the patient is enrolled in a hospice program (as defined in
280280 11 IC 16-25-1.1-4).
281281 12 SECTION 3. IC 36-8-10-21, AS AMENDED BY P.L.216-2007,
282282 13 SECTION 55, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
283283 14 JULY 1, 2025]: Sec. 21. (a) Except as provided in IC 11-12-12, this
284284 15 section applies to any county that has a jail commissary that sells
285285 16 merchandise to inmates.
286286 17 (b) A jail commissary fund is established, referred to in this section
287287 18 as "the fund". The fund is separate from the general fund, and money
288288 19 in the fund does not revert to the general fund.
289289 20 (c) The sheriff, or the sheriff's designee, shall deposit all money
290290 21 from commissary sales into the fund, which the sheriff or the sheriff's
291291 22 designee shall keep in a depository designated under IC 5-13-8.
292292 23 (d) The sheriff, or the sheriff's designee, at the sheriff's or the
293293 24 sheriff's designee's discretion and without appropriation by the county
294294 25 fiscal body, may disburse money from the fund for:
295295 26 (1) merchandise for resale to inmates through the commissary;
296296 27 (2) expenses of operating the commissary, including, but not
297297 28 limited to, facilities and personnel;
298298 29 (3) special training in law enforcement for employees of the
299299 30 sheriff's department;
300300 31 (4) equipment installed in the county jail;
301301 32 (5) equipment, including vehicles and computers, computer
302302 33 software, communication devices, office machinery and
303303 34 furnishings, cameras and photographic equipment, animals,
304304 35 animal training, holding and feeding equipment and supplies, or
305305 36 attire used by an employee of the sheriff's department in the
306306 37 course of the employee's official duties;
307307 38 (6) an activity provided to maintain order and discipline among
308308 39 the inmates of the county jail;
309309 40 (7) an activity or program of the sheriff's department intended to
310310 41 reduce or prevent occurrences of criminal activity, including the
311311 42 following:
312312 2025 IN 386—LS 6178/DI 116 8
313313 1 (A) Substance abuse.
314314 2 (B) Child abuse.
315315 3 (C) Domestic violence.
316316 4 (D) Drinking and driving.
317317 5 (E) Juvenile delinquency;
318318 6 (8) expenses related to the establishment, operation, or
319319 7 maintenance of the sex and violent offender registry web site
320320 8 under IC 36-2-13-5.5; or
321321 9 (9) any other purpose that benefits the sheriff's department that is
322322 10 mutually agreed upon by the county fiscal body and the county
323323 11 sheriff.
324324 12 Money disbursed from the fund under this subsection must be
325325 13 supplemental or in addition to, rather than a replacement for, regular
326326 14 appropriations made to carry out the purposes listed in subdivisions (1)
327327 15 through (8). (9).
328328 16 (e) The sheriff shall maintain a record of the fund's receipts and
329329 17 disbursements. The state board of accounts shall prescribe the form for
330330 18 this record. The sheriff shall semiannually provide a copy of this record
331331 19 of receipts and disbursements to the county fiscal body. The
332332 20 semiannual reports are due on July 1 and December 31 of each year.
333333 2025 IN 386—LS 6178/DI 116